Patents by Inventor Todd W. Seeley

Todd W. Seeley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Porcine collagens and gelatins
    Publication number: 20040005663
    Abstract: The present invention provides animal collagens and gelatins and compositions thereof, and methods of producing the same.
    Type: Application
    Filed: March 26, 2003
    Publication date: January 8, 2004
    Inventors: Marcum P. Bell, Thomas B. Neff, James W. Polarek, Todd W. Seeley
  • Detection of loss of the wild-type huBUB1 gene
    Patent number: 6489137
    Abstract: Methods are provided for assessing mutations and/or loss of the huBUB1 gene in human tumors. Loss of wild-type huBUB1 genes is involved in neoplastic development. Therapeutic regimens can be planned on the basis of the mutational status of huBUB1.
    Type: Grant
    Filed: June 11, 1998
    Date of Patent: December 3, 2002
    Assignee: Chiron Corporation
    Inventor: Todd W. Seeley
  • huBUB3 gene involved in human cancers
    Publication number: 20020160403
    Abstract: Methods are provided for assessing mutations and/or loss of the huBUB3 gene in human tumors. Loss of wild-type huBUB3 genes is involved in neoplastic development. Therapeutic regimens can be planned on the basis of the mutational status of huBUB3.
    Type: Application
    Filed: February 27, 2002
    Publication date: October 31, 2002
    Applicant: Chiron Corporation
    Inventor: Todd W. Seeley
  • DETECTION OF LOSS OF THE WILD-TYPE HUBUB1 GENE
    Publication number: 20020123042
    Abstract: Methods are provided for assessing mutations and/or loss of the huBUB1 gene in human tumors. Loss of wild-type huBUB1 genes is involved in neoplastic development. Therapeutic regimens can be planned on the basis of the mutational status of huBUB1.
    Type: Application
    Filed: June 11, 1998
    Publication date: September 5, 2002
    Inventor: TODD W. SEELEY
  • huBUB3 gene involved in human cancers
    Patent number: 6410312
    Abstract: Methods are provided for assessing mutations and/or loss of the huBUB3 gene in human tumors. Loss of wild-type huBUB3 genes is involved in neoplastic development. Therapeutic regimens can be planned on the basis of the mutational status of huBUB3.
    Type: Grant
    Filed: December 10, 1998
    Date of Patent: June 25, 2002
    Assignee: Chiron Corporation
    Inventor: Todd W. Seeley
  • Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers
    Publication number: 20020049180
    Abstract: Inhibitors of KIAA0175 are provided that reduce the expression or biological activities of KIAA0175, p53 and/or p21 in a mammalian cell. KIAA0175 inhibitors include anti-sense molecules, ribozymes, antibodies and antibody fragments, proteins and polypeptides as well as small molecules. KIAA0175 inhibitors find use in compositions and methods for decreasing KIAA0175, p53 and/or p21 gene expression as well as methods for increasing the chemo and/or radiosensitivity of mammalian cells, including tumor cells, methods for decreasing the side effects of cancer therapy and methods for treating neoplastic diseases.
    Type: Application
    Filed: May 30, 2001
    Publication date: April 25, 2002
    Inventors: Bin Wu, Todd W. Seeley, Lewis T. Williams